thérapie par cellules souches en Ukraine

Post-PCI Selection of Antithrombotic Therapy

Post-PCI Selection of Antithrombotic Therapy Improvements in antithrombotic pharmacotherapy have led to important reductions in complications after percutaneous coronary intervention. By John P. Vavalle, MARYLAND, and Robert A. Harrington, MD Since the introduction of percutaneous coronary intervention (PCI) plus que 3 decades ago, the rates of procedural success and associated Lire la suite…

thérapie par cellules souches en Ukraine

Pharma companies list

Abbott Lab. Actavis Group Adamed Alembic Ltd Alkem Lab. Allergan Amoun Anton Hubner Astellas Pharma Europe AstraZeneca Bausch & Lomb Bayer Beijing Union Pharmaceutical Factory Belco Pharma bene-Arzneimittel Beres Pharmaceuticals Ltd Berlin-Chemie AG (Menarini Group) Besins Healthcare Biomed Bionorica AG Biotehnos Boehringer Ingelheim Boiron Bosnalijek Cesra Arzneimittel GmbH & Co. Lire la suite…

thérapie par cellules souches